一种基于支柱[5]arene的硫化超分子宿主,用于逆胆诱导的神经肌肉阻塞逆转
Mengyao Li1,2, Yujie Cheng3, Rui Fei1,2
1Key Laboratory & Engineering Laboratory of Lymphatic Surgery of Jilin Province, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130031, P. R. China. qishaolong@jlu.edu.cn.
概括
一种新型的酸柱[5]arene (SP[5]A) 通过封装药物来逆转酸胆诱导的神经肌肉阻塞. 这种宿主与客人的相互作用有效地消除了顺胆,并减轻了不良影响.
科学领域:
- 超分子化学 超分子化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 神经肌肉阻断剂,如顺胆在麻醉中至关重要.
- 扭转神经肌肉阻塞对于患者的康复至关重要.
- 目前的逆转策略可能有局限性或副作用.
研究的目的:
- 设计和评估一种新型的每硫柱[5]arene (SP[5]A) 作为糖胆的特定逆转剂.
- 为了研究SP[5]A和 succinylcholine之间的宿主-客人识别机制.
- 评估SP[5]A在缓解顺胆诱导的不良反应中的有效性.
主要方法:
- 对硫化支柱[5]arene (SP[5]A) 的合成和表征.
- 在体外和体内研究,以评估SP[5]A.的结合亲和力和囊封化胆.
- 在临床前模型中评估SP[5]A逆转神经肌肉阻塞的能力.
- 评估SP[5]A对顺胆诱导的高胆血症,心律失常和狂犬病的影响.
主要成果:
- SP[5]A已成功合成,并显示了对顺胆的高结合亲和力 (10M-1).
- SP[5]A在活体中快速,具体地识别和封装了基尼尔胆.
- SP[5]A有效地逆转了由顺胆诱导的神经肌肉阻塞.
- [5]SPA减轻了不良反应,如高胆血症,心律失常和狂犬病.
结论:
- 超硫柱[5]arene (SP[5]A) 是一种强大且特定的宿主-客体复合剂.
- SP[5]A显示出作为苏基尼尔胆诱导的神经肌肉阻塞的逆转剂的显著潜力.
- SP[5]A提供了一种有前途的策略,可以改善麻醉期间和之后的患者安全.
相关概念视频
Depolarizing Blockers: Pharmocokinetics
298
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
298
Depolarizing Blockers: Mechanism of Action
1.1K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.1K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.4K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.4K
Skeletal Muscle Relaxants: Adverse Effects
325
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
325
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
377
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
377
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
503
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
503


